Auddia Inc. (NASDAQ: AUUD) has spotlighted its subsidiary Influence Healthcare, a healthtech company that uses artificial intelligence and vertical integration to enable surgeons to lead value-based care (VBC) in high-spend specialties. The announcement comes as Auddia prepares to file its Form S-4 with the Securities and Exchange Commission later this week, a key step in its planned merger with Thramann Holdings LLC.
Influence Healthcare is designed as a structural alternative to hospital employment and private-equity rollups, which often reduce physician autonomy or prioritize financial engineering over clinical leadership. The company organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments in spine, total joints, and other high-cost specialties. These VBEs are supported by advanced AI workflows that automate documentation, coding, episode validation, care-pathway coordination, staffing, supply chain, and logistics, allowing surgeons to focus on patient care.
“Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care,” said Jeff Thramann, M.D., CEO of Auddia and founder of Influence Healthcare, in a press release. “Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price.”
The model is built on a premise that physicians deliver value and should lead the system. Influence Healthcare creates surgeon-led enterprises where clinicians retain governance authority, episode-based economics flow to them, and facilities participate through aligned partnerships rather than ownership. AI reduces administrative overhead, which Dr. Thramann noted is a major driver of burnout and rising costs.
Post-merger, Influence Healthcare will leverage shared AI services from McCarthy Finney, the combined company’s new name, to deploy agentic-AI workflows that automate clinical documentation, coding, billing preparation, prior authorization, care-pathway adherence monitoring, and communication across episodes. These workflows aim to eliminate the need for multiple administrative staff per surgeon.
“AI should not replace physicians, it should replace the administrative friction that prevents physicians from practicing at the top of their license,” Dr. Thramann said.
Influence Healthcare is one of three subsidiaries, along with LT350 and Voyex, that will join Auddia upon closing of the merger. LT350 is a distributed AI data center company with patents on solar parking lot canopy infrastructure, while Voyex is a travel services platform using agentic AI and charter aircraft to address flight delays. The combined entity, McCarthy Finney, will trade under the ticker MCFN on Nasdaq.
Auddia anticipates filing the S-4 later this week, which will contain a proxy statement and prospectus for stockholder approval. The merger is expected to close after regulatory and shareholder approvals. For more information on Influence Healthcare, visit www.influencehealthcare.com. Updates on Auddia are available at its newsroom.
